"Natural History" Study of Choroideremia

Terminated

• Conditions: Choroideremia

• Registration Number: NCT02994368
• Lead Sponsor: 4D Molecular Therapeutics

Brief Summary

The purpose of this study is to understand the rate of progression of all stages of choroideremia using a variety of assessments performed in the clinic including visual field measures, specialized photography of the eye and participant-reported visual problems

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12
• Study First Submitted: 2016-12-13
• Study First Submitted QC: 2016-12-14
• Study First Posted: 2016-12-15
• Primary Completion: 2021-10
• Study Completion: 2021-10
• Status Verified: 2022-01
• Last Update Submitted: 2022-01-04
• Last Update Posted: 2022-01-06

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Male
• Target Recruitment: 57

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of progression of disease	4 years	A variety of psychophysical, anatomical and image-based endpoints

Trial Locations

Locations (4)

Retina Foundation of the Southwest; 🇺🇸 Dallas, Texas, United States

Baylor College of Medicine, Ophthalmology-Cullen Eye Center; 🇺🇸 Houston, Texas, United States

Moran Eye Center, University of Utah; 🇺🇸 Salt Lake City, Utah, United States

University of Alberta; 🇨🇦 Edmonton, Alberta, Canada